There were no significant differences in the incidence rates of concomitant testicular infiltration, central nervous system leukemia, intracranial hemorrhage, hepatosplenomegaly, and bone pain at the diagnosis of the disease in patients with different CRLF2 expression levels (Supplementary Table 1). This evidence concerns the gene CRLF2 and intracranial hemorrhage.